Novo Nordisk Cuts Deep: Ozempic Era Shifting?
Update: 2025-09-10
Description
Novo Nordisk slashes 9,000 jobs amidst fierce weight-loss drug competition! Find out why the Ozempic and Wegovy giant is restructuring to save billions, revising profit forecasts, and how this impacts the future of the booming obesity market.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
